Skip to main content
Have a personal or library account? Click to login
Treatment outcomes and survival in patients with primary central nervous system lymphomas treated between 1995 and 2010 – a single centre report Cover

Treatment outcomes and survival in patients with primary central nervous system lymphomas treated between 1995 and 2010 – a single centre report

Radiology and Oncology
Volume 46 (2012): Issue 4 (December 2012)
By:   
Open Access
|Nov 2012
References

References

  1. 1. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.2006;27-37.
    Open DOISearch in Google Scholar
  2. 2. Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.2011;1414-8.
    Open DOISearch in Google Scholar
  3. 3. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958-1989.1994;1383-97.
    Open DOISearch in Google Scholar
  4. 4. Fine HA, Mayer RJ. Primary central nervous system lymphoma.1993;1093-104.
    Open DOISearch in Google Scholar
  5. 5. Hochberg FH, Miller DC. Primary central nervous system lymphoma.1988;835-53.
    Open DOISearch in Google Scholar
  6. 6. Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Savkova RF, et al. Solid tumors in young children in Moscow Region of Russian Federation.2008;39-44.
    Open DOISearch in Google Scholar
  7. 7. Schabet M. Epidemiology of primary CNS lymphoma.1999;199-201.
    Open DOISearch in Google Scholar
  8. 8. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma.2008;1830-44.
    Open DOISearch in Google Scholar
  9. 9. Herrlinger U, Schabet M, Clemens M, Kortmann RD, Petersen D, Will BE, et al. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.1998;257-64.
    Open DOISearch in Google Scholar
  10. 10. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases.2000;261-6.
    Open DOISearch in Google Scholar
  11. 11. Linnert M, Iversen HK, Gehl J. Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy.2012;271-8.
    Open DOISearch in Google Scholar
  12. 12. Tezcan Y, Koc M. 3-D conformal radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma multiforme and evaluation of prognostic factors.2011;213-9.
    Open DOISearch in Google Scholar
  13. 13. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma.1998;859-63.
    Open DOISearch in Google Scholar
  14. 14. Cher L, Glass J, Harsh GR, Hochberg FH. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiation therapy: preliminary results.1996;1757-9.
    Open DOISearch in Google Scholar
  15. 15. Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, et al. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.1998;110-24.
    Search in Google Scholar
  16. 16. Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Schmidt-Wolf I, Helmstaedter C, et al. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.2001;118-22.
    Open DOISearch in Google Scholar
  17. 17. Blay JY. Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects.1997;976-80.
    Search in Google Scholar
  18. 18. Pech IV, Peterson K, Cairncross JG. Chemotherapy for brain tumors.1998;537-53.
    Search in Google Scholar
  19. 19. Ferreri AJ, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.2000;927-37.
    Open DOISearch in Google Scholar
  20. 20. Stanic K, Kovac V. Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology Ljubljana.2010;213-9.
    Open DOISearch in Google Scholar
  21. 21. Horvat M, Jezersek Novakovic B. Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma.2010;232-8.
    Open DOISearch in Google Scholar
  22. 22. Gregoric B, Zadnik V, Jezersek Novakovic B. The diffuse large B-cell lymphoma - where do we stand now in everyday clinical practice.2012;153-9.
    Open DOISearch in Google Scholar
  23. 23. O’Neill BP, O’Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL. Primary central nervous system non-Hodgkin’s lymphoma: survival advantages with combined initial therapy.1995;663-73.
    Open DOISearch in Google Scholar
  24. 24. Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.1996;556-64.
    Open DOISearch in Google Scholar
  25. 25. Ferreri AJ, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, et al. A multicenter study of treatment of primary CNS lymphoma.2002;1513-20.
    Open DOISearch in Google Scholar
  26. 26. Shibamoto Y, Ogino H, Suzuki G, Takemoto M, Araki N, Isobe K, et al. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.2008;560-8.
    Open DOISearch in Google Scholar
  27. 27. Joerger M, Huitema AD, Krähenbühl S, Schellens JH, Cerny T, Reni M, et al. Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.2010;673-7.
    Open DOISearch in Google Scholar
  28. 28. Abrey LE, Batchelor TT, Ferreri AJ, Gospodarowicz MJ, Pulczynski EJ, Zucca E, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.2005;5034-43.
    Open DOISearch in Google Scholar
  29. 29. Uhm JE, Kim KH, Yi SY, Chang MH, Park KW, Kong DS, et al. A retrospective study to compare two methotrexate-based ragimens for primary central nervous system lymphoma.2009;1110-8.
    Open DOISearch in Google Scholar
  30. 30. Lim T, Kim SJ, Kim K, Lee Ji, Lim do H, Lee DJ, et al. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.2011;1391-8.
    Open DOISearch in Google Scholar
  31. 31. Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P. Primary central nervous system lymphoma: from clinical presentation to diagnosis.1999;219-26.
    Open DOISearch in Google Scholar
  32. 32. Shibamoto Y, Sasai K, Oya N, Hiraoka M. Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.1999;161-7.
    Open DOISearch in Google Scholar
  33. 33. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome.1994;188-95.
    Open DOISearch in Google Scholar
  34. 34. O′Brien PC, Roos, DE, Liew KH, Trotter GE, Barton MB, Walker QJ, et al. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group.1996;424-7.
    Search in Google Scholar
  35. 35. Ferreri AJ, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.2009;1512-20.
    Open DOISearch in Google Scholar
  36. 36. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, et al. Non-Hodgkin’s lymphoma of the brain: can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315.1992;9-17.
    Open DOISearch in Google Scholar
  37. 37. Laack NN, Ballman KV, Brown PB, O’Neill BP; North Central Cancer Treatment Group. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.2006;1429-39.
    Open DOISearch in Google Scholar
  38. 38. Laperriere NJ, Cerezo L, Milosevic MF, Wong CS, Patterson B, Panzarella T. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy.1997;247-52.
    Open DOISearch in Google Scholar
  39. 39. Brada M, Hjiyiannakis D, Hines F, Traish D, Ashley S. Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).1998;1157-62.
    Open DOISearch in Google Scholar
  40. 40. O’Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.2000;519-26.
    Open DOISearch in Google Scholar
  41. 41. Niemiec M, Głogowski M, Tyc-Szczepaniak D, Wierzchowski M, Kępka L. Characteristics of long-term survivors of brain metastases from lung cancer.2011;49-53.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-012-0048-5 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 346 - 353
Submitted on: Jun 9, 2012
Accepted on: Sep 1, 2012
Published on: Nov 9, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
primary central nervous system lymphomas,
treatment outcomes,
survival
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2012 Barbara Jezersek Novakovic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 4 (December 2012)
Previous article
Next article